New data reinforces safety profile of Enbrel

Published: 2011-05-18 06:56:00

Updated: 2011-05-18 06:56:00

There is good news for patients with rheumatoid arthritis (RA), as the latest study confirming the established safety profile of Enbrel (etanercept) for up to 10 years.

Wyeth Korea has recently announced the presentation of additional data that showed that the safety profile of Enbrel was main...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK